Optometrist Vance Thompson Vision Sioux Falls, South Dakota, United States
Disclosure(s): No relevant disclosure to display
Disclosure(s):
Mitchel Ibach, OD: No relevant disclosure to display
Glaucoma’s chronic progressive nature necessitates pairing and leveraging multiple treatments with a goal of buying years of non-progression. Eyecare providers are currently armed with topical medications, drug delivery, laser surgeries, and intraocular surgeries to treat intraocular pressure and ultimately glaucoma. Using patient cases, this lecture will challenge attendees to work through the glaucoma diagnostics, decide on treatment necessity, and ultimately select the treatment modality. Peer-reviewed evidence will be reviewed.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Discuss ocular hypertension, disease risk factors, and when to treat versus monitor
Review the legendary and newer topical glaucoma medications with a focus on mechanism of action
Compare and contrast treatment approaches for low tension glaucoma versus primary open-angle glaucoma
Introduce minimally invasive glaucoma surgeries (MIGs) and when to employ various technologies
Review patient preferences for different treatment modalities. How we decide
Define interventional glaucoma and review where SLT and drug delivery fits in 2024